128 related articles for article (PubMed ID: 13802440)
1. [Relations between chemical constitution and carbonic anhydrase inhibition in a series of sulfamides].
BONATI F; SALA R
Boll Soc Ital Biol Sper; 1959 Dec; 35():1749-51. PubMed ID: 13802440
[No Abstract] [Full Text] [Related]
2. [Relation between the saluretic activity and the carbonic anhydrase inhibitory effect of aromatic sulfonamides].
KOBINGER W; KATIC U; LUND FJ
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1961; 240():469-82. PubMed ID: 13757294
[No Abstract] [Full Text] [Related]
3. [On the question of sulfonamide binding to carbonic anhydrase].
KELLER H; MUELLER-BEISSENHIRTZ W; OHLENBUSCH HD
Hoppe Seylers Z Physiol Chem; 1959 Oct; 316():172-85. PubMed ID: 14405226
[No Abstract] [Full Text] [Related]
4. [PROGRESS OF CARBONIC ANHYDRASE INHIBITORS].
KINOSHITA Y; HIRASAWA Y
Sogo Rinsho; 1964 May; 13():847-57. PubMed ID: 14156126
[No Abstract] [Full Text] [Related]
5. [ACTION OF DISULFONAMIDOPHENYLHYDRAZINES ON CARBONIC ANHYDRASE)].
LESPAGNOL A; BAR D; OSTEUX R; MIZON-CAPRON C
Ann Pharm Fr; 1964; 22():411-6. PubMed ID: 14193621
[No Abstract] [Full Text] [Related]
6. The problem of bioassay and comparative potency of diuretics. II. Carbonic anhydrase inhibitors as oral diuretics.
FORD RV; SPURR CL; MOYER JH
Circulation; 1957 Sep; 16(3):394-8. PubMed ID: 13461246
[No Abstract] [Full Text] [Related]
7. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors.
Winum JY; Cecchi A; Montero JL; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jul; 15(13):3302-6. PubMed ID: 15908201
[TBL] [Abstract][Full Text] [Related]
8. The synthesis of novel sulfamides derived from β-benzylphenethylamines as acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase enzymes inhibitors.
Akıncıoğlu A; Kocaman E; Akıncıoğlu H; Salmas RE; Durdagi S; Gülçin İ; Supuran CT; Göksu S
Bioorg Chem; 2017 Oct; 74():238-250. PubMed ID: 28866249
[TBL] [Abstract][Full Text] [Related]
9. Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors.
Akıncıoğlu A; Akbaba Y; Göçer H; Göksu S; Gülçin İ; Supuran CT
Bioorg Med Chem; 2013 Mar; 21(6):1379-85. PubMed ID: 23394864
[TBL] [Abstract][Full Text] [Related]
10. Investigation of sulfonamides inhibition of carbonic anhydrase enzyme using multiphotometric and electrochemical techniques.
Bourais I; Maliki S; Mohammadi H; Amine A
Enzyme Microb Technol; 2017 Jan; 96():23-29. PubMed ID: 27871381
[TBL] [Abstract][Full Text] [Related]
11. [Effects of carbonic anhydrase inhibitors on sulfonamide excretion].
LINDNER A; RUDAS B
Wien Klin Wochenschr; 1959 Dec; 71():953-6. PubMed ID: 14417171
[No Abstract] [Full Text] [Related]
12. Inhibition of pancreatic secretion by the carbonic anhydrase inhibitor, 2-acetylamino-1,3,4, thiadiazole-5-sulfonamide (compound No. 6063).
BIRNBAUM D; HOLLANDER F
Proc Soc Exp Biol Med; 1952 Oct; 81(1):23-4. PubMed ID: 13047303
[No Abstract] [Full Text] [Related]
13. Benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulfonamides as inhibitors of carbonic anhydrase.
Dudutiene V; Baranauskiene L; Matulis D
Bioorg Med Chem Lett; 2007 Jun; 17(12):3335-8. PubMed ID: 17442568
[TBL] [Abstract][Full Text] [Related]
14. The electronic structures and pharmacological activities of sulfanilamide derivatives and carbonic anhydrase inhibitors with the same sulfonamide moiety.
Yonezawa T; Muro I; Kato H; Kimura M
Mol Pharmacol; 1969 Sep; 5(5):446-54. PubMed ID: 4898668
[No Abstract] [Full Text] [Related]
15. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.
Abdoli M; Angeli A; Bozdag M; Carta F; Kakanejadifard A; Saeidian H; Supuran CT
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1071-1078. PubMed ID: 28753093
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibition. V. N5-substituted 2-acetylamino-1,3,4-thiadiazole-5-sulfonamides: metabolic conversion and use as control substances.
MAREN TH
J Pharmacol Exp Ther; 1956 Aug; 117(4):385-401. PubMed ID: 13358050
[No Abstract] [Full Text] [Related]
18. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
19. The effects of the carbonic anhydrase inhibitor 6063 on electrolytes and acid-base balance in two normal subjects and two patients with respiratory acidosis.
NADELL J
J Clin Invest; 1953 Jul; 32(7):622-9. PubMed ID: 13069607
[No Abstract] [Full Text] [Related]
20. QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices.
Melagraki G; Afantitis A; Sarimveis H; Igglessi-Markopoulou O; Supuran CT
Bioorg Med Chem; 2006 Feb; 14(4):1108-14. PubMed ID: 16213737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
